| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.069 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |